Journal Home > Volume 12 , Issue 3

Nano- and micro-particles are being increasingly used to tune interfacial frictional properties in diverse applications, from friction modifiers in industrial lubrication to enhanced biological fluids in human osteoarthritic joints. Here, we assessed the tribological properties of a simulated synovial fluid enriched with non-spherical, poly lactic-co-glycolic acid (PLGA) microparticles (μPL) that have been previously demonstrated for the pharmacological management of osteoarthritis (OA). Three different μPL configurations were fabricated presenting a 20 μm × 20 μm square base and a thickness of 5 μm (thin, 5H μPL), 10 μm (10H μPL), and 20 μm (cubical, 20H μPL). After extensive morphological and physicochemical characterizations, the apparent Young’s modulus of the μPL was quantified under compressive loading returning an average value of ~ 6 kPa, independently of the particle morphology. Then, using a linear two-axis tribometer, the static (µs) and dynamic (µd) friction coefficients of the μPL-enriched simulated synovial fluid were determined in terms of particle configuration and concentration, varying from 0 (fluid only) to 6×105 μPL/mL. The particle morphology had a modest influence on friction, possibly because the μPL were fully squeezed between two mating surfaces by a 5.8 N normal load realizing boundary-like lubrication conditions. Differently, friction was observed to depend on the dimensionless parameter Ω, defined as the ratio between the total volume of the μPL enriching the simulated synovial fluid and the volume of the fluid itself. Both coefficients of friction were documented to grow with Ω reaching a plateau of µs ~ 0.4 and µd ~ 0.15, already at Ω ~ 2×10-3. Future investigations will have to systematically analyze the effect of sliding velocity, normal load, and rigidity of the mating surfaces to elucidate in full the tribological behavior of μPL in the context of osteoarthritis.


menu
Abstract
Full text
Outline
Electronic supplementary material
About this article

Tribological behavior of shape-specific microplate-enriched synovial fluids on a linear two-axis tribometer

Show Author's information Agnese FRAGASSI1,2Antonietta GRECO1Martina DI FRANCESCO1Luca CESERACCIU3Aiman ABU AMMAR4Israel DVIR5Thomas Lee MOORE1Haytam KASEM5,Paolo DECUZZI1,( )
Laboratory of Nanotechnology for Precision Medicine, Fondazione Istituto Italiano di Tecnologia, Genova 16163, Italy
Department of Chemistry and Industrial Chemistry, University of Genova, Genoa 16146, Italy
Materials Characterization Facility, Istituto Italiano di Tecnologia, Genova 16163, Italy
Department of Pharmaceutical Engineering, Azrieli College of Engineering Jerusalem, Jerusalem 9103501, Israel
Department of Mechanical Engineering, Azrieli College of Engineering Jerusalem, Jerusalem 9103501, Israel

Haytam KASEM and Paolo DECUZZI contributed equally to this work.

Abstract

Nano- and micro-particles are being increasingly used to tune interfacial frictional properties in diverse applications, from friction modifiers in industrial lubrication to enhanced biological fluids in human osteoarthritic joints. Here, we assessed the tribological properties of a simulated synovial fluid enriched with non-spherical, poly lactic-co-glycolic acid (PLGA) microparticles (μPL) that have been previously demonstrated for the pharmacological management of osteoarthritis (OA). Three different μPL configurations were fabricated presenting a 20 μm × 20 μm square base and a thickness of 5 μm (thin, 5H μPL), 10 μm (10H μPL), and 20 μm (cubical, 20H μPL). After extensive morphological and physicochemical characterizations, the apparent Young’s modulus of the μPL was quantified under compressive loading returning an average value of ~ 6 kPa, independently of the particle morphology. Then, using a linear two-axis tribometer, the static (µs) and dynamic (µd) friction coefficients of the μPL-enriched simulated synovial fluid were determined in terms of particle configuration and concentration, varying from 0 (fluid only) to 6×105 μPL/mL. The particle morphology had a modest influence on friction, possibly because the μPL were fully squeezed between two mating surfaces by a 5.8 N normal load realizing boundary-like lubrication conditions. Differently, friction was observed to depend on the dimensionless parameter Ω, defined as the ratio between the total volume of the μPL enriching the simulated synovial fluid and the volume of the fluid itself. Both coefficients of friction were documented to grow with Ω reaching a plateau of µs ~ 0.4 and µd ~ 0.15, already at Ω ~ 2×10-3. Future investigations will have to systematically analyze the effect of sliding velocity, normal load, and rigidity of the mating surfaces to elucidate in full the tribological behavior of μPL in the context of osteoarthritis.

Keywords: tribology, synovial fluid, osteoarthritis, microparticles, pin on plate

References(32)

[1]
Loeser R F, Collins J A, Diekman B O. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol 12: 412–420 (2016)
[2]
Martel-Pelletier J, Barr A, Cicuttini F, Conaghan P, Cooper C, Goldring M, Goldring S R, Jones G, Teichtahl A J, Pelletier J P. Osteoarthritis. Nat Rev Dis Primers 2: 16072 (2016)
[3]
Menon J, Mishra P. Health care resource use, health care expenditures and absenteeism costs associated with osteoarthritis in US healthcare system. Osteoarthr Cartilage 26: 480–484 (2018)
[4]
Turkiewicz A, Petersson I F, Björk J, Hawker G, Dahlberg L E, Lohmander L S, Englund M. Current and future impact of osteoarthritis on health care: A population-based study with projections to year 2032. Osteoarthr Cartilage 22: 1826–1832 (2014)
[5]
Evans C H, Kraus V B, Setton L A. Progress in intra-articular therapy. Nat Rev Rheumatol 10: 11–22 (2014)
[6]
Jones I A, Togashi R, Wilson M L, Heckmann N, Vangsness Jr C T. Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol 15: 77–90 (2019)
[7]
Kolasinski S L, Neogi T, Hochberg M C, Oatis C, Guyatt G, Block J, Callahan L, Copenhaver C, Dodge C, Felson D, et al. 2019 American college of Rheumatology/Arthritis foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol 72: 220–233 (2020)
[8]
Bannuru R R, Osani M, Vaysbrot E, Arden N, Bennell K, Bierma-Zeinstra S, Kraus V B, Lohmander L S, Abbott J H, Bhandari M, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartilage 27: 1578–1589 (2019)
[9]
Hepper C T, Halvorson J J, Duncan S T, Gregory A J, Dunn W R, Spindler K P. The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: A systematic review of level I studies. J Am Acad Orthop Sur 17: 638–646 (2009)
[10]
Bannuru R R, Natov N S, Obadan I E, Price L L, Schmid C H, McAlindon T E. Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis: A systematic review and meta-analysis. Arthrit Care Res 61: 1704–1711 (2009)
[11]
Wehling P, Evans C, Wehling J, Maixner W. Effectiveness of intra-articular therapies in osteoarthritis: A literature review. Ther adv musculoskel 9: 183–196 (2017)
[12]
Brown S, Kumar S, Sharma B. Intra-articular targeting of nanomaterials for the treatment of osteoarthritis. Acta Biomater 93: 239–257 (2019)
[13]
Larsen C, Østergaard J, Larsen S W, Jensen H, Jacobsen S, Lindegaard C, Andersen P H. Intra-articular depot formulation principles: Role in the management of postoperative pain and arthritic disorders. J Pharm Sci 97: 4622–4654 (2008)
[14]
Maudens P, Jordan O, Allémann E. Recent advances in intra-articular drug delivery systems for osteoarthritis therapy. Drug Discovery Today 23: 1761–1775 (2018)
[15]
Dong J, Jiang D, Wang Z, Wu G, Miao L, Huang L. Intra-articular delivery of liposomal celecoxib–hyaluronate combination for the treatment of osteoarthritis in rabbit model. Int J Pharm 441: 285–290 (2013)
[16]
Bedingfield S K, Colazo J M, Yu F, Liu D D, Jackson M A, Himmel L E, Cho H, Crofford L J, Hasty K, Duvall C L. Amelioration of post-traumatic osteoarthritis via nanoparticle depots delivering small interfering RNA to damaged cartilage. Nature Biomed Eng 5: 1069–1083 (2021)
[17]
Bodick N, Lufkin J, Willwerth C, Kumar A, Bolognese J, Schoonmaker C, Ballal R, Hunter D, Clayman M. An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: A randomized clinical trial. J Bone Joint Surg Am 97: 877–888 (2015)
[18]
Di Francesco M, Fragassi A, Pannuzzo M, Ferreira M, Brahmachari S, Decuzzi P. Management of osteoarthritis: From drug molecules to nano/micromedicines. Wiley Interdiscip Rev Nanomed Nanobiotechnol 14: e1780 (2022)
[19]
Pradal J, Maudens P, Gabay C, Seemayer C A, Jordan O, Allémann E. Effect of particle size on the biodistribution of nano-and microparticles following intra-articular injection in mice. Int J Pharm 498: 119–129 (2016)
[20]
Kang M L, Ko J Y, Kim J E, Im G I. Intra-articular delivery of kartogenin-conjugated chitosan nano/microparticles for cartilage regeneration. Biomaterials 35: 9984–9994 (2014)
[21]
Di Francesco M, Bedingfield S K, Di Francesco V, Colazo J M, Yu F, Ceseracciu L, Bellotti E, Di Mascolo D, Ferreira M, Himmel L E, et al. Shape-defined microplates for the sustained intra-articular release of dexamethasone in the management of overload-induced osteoarthritis. ACS Appl Mater Interfaces 13: 31379–31392 (2021)
[22]
Ozkan H, Di Francesco M, Willcockson H, Valdés-Fernández J, Di Francesco V, Granero-Moltó F, Prosper F, Decuzzi P, Longobardi L. Sustained inhibition of CC-chemokine receptor-2 via intraarticular deposition of polymeric microplates in post-traumatic osteoarthritis. Drug Delivery Transl Res 13: 689–701 (2023)
[23]
Bedingfield S K, Colazo J M, Di Francesco M, Yu F, Liu D D, Di Francesco V, Himmel L E, Gupta M K, Cho H, Hasty K A, et al. Top-down fabricated microplates for prolonged, intra-articular matrix metalloproteinase 13 siRNA nanocarrier delivery to reduce post-traumatic osteoarthritis. ACS Nano 15: 14475–14491 (2021)
[24]
Di Francesco M, Primavera R, Romanelli D, Palomba R, Pereira R C, Catelani T, Celia C, Di Marzio L, Fresta M, Di Mascolo D, Decuzzi, P. Hierarchical microplates as drug depots with controlled geometry, rigidity, and therapeutic efficacy. ACS Appl Mater Interfaces 10: 9280–9289 (2018)
[25]
Dvir I, Abd-Rbo K, Segal D, Kandel LA, Kasem H. New experimental methodology to evaluate lubrication properties of synovial fluid containing worn tissue particles in osteoarthritis patients. Friction 11(11): 2132–2141 (2023)
[26]
Li X, Dai B, Guo J, Zheng L, Guo Q, Peng J, Xu J, Qing L. Nanoparticle–cartilage interaction: Pathology-based intra-articular drug delivery for osteoarthritis therapy. Nano-Micro Lett 13: 149 (2021)
[27]
Tevet O, Von-Huth P, Popovitz-Biro R, Rosentsveig R, Wagner H D, Tenne R. Friction mechanism of individual multilayered nanoparticles. Proc Natl Acad Sci 108: 19901–19906 (2011)
[28]
Shi J, Zhu X, Sun K, Fang L. Movement pattern of an ellipsoidal nanoparticle confined between solid surfaces: Theoretical model and molecular dynamics simulation. Friction 9(5): 1098–1109 (2021)
[29]
Li P P, Ji L, Li H X, Chen L, Liu X H, Zhou H D, Chen J M. Role of nanoparticles in achieving macroscale superlubricity of graphene/nano-SiO2 particle composites. Friction 10(9): 1305–1316 (2022)
[30]
Fukubayashi T, Kurosawa H. The contact area and pressure distribution pattern of the knee: A study of normal and osteoarthrotic knee joints. Acta Orthop Scand 51: 871–879 (1980)
[31]
Schmidt T A, Gastelum N S, Nguyen Q T, Schumacher B L, Sah R L. Boundary lubrication of articular cartilage: Role of synovial fluid constituents. Arthritis Rheumatol 56: 882–891 (2007)
[32]
Link J M, Salinas E Y, Hu J C, Athanasiou K A. The tribology of cartilage: Mechanisms, experimental techniques, and relevance to translational tissue engineering. Clin Biomech 79: 104880 (2020)
File
40544_0794_ESM.pdf (1 MB)
Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 18 June 2023
Accepted: 02 July 2023
Published: 04 December 2023
Issue date: March 2024

Copyright

© The author(s) 2023.

Acknowledgements

Agnese FRAGASSI (A.F.) and Paolo DECUZZI (P.D.) acknowledge the partial support of the Horizon 2020 Marie Skłodowska-Curie Actions project "Shaping the Mechano-Pharmacological properties of Microparticles and Extracellular Vesicles for the Treatment of Osteoarthritis–MEPHOS" with Grant agreement 872648. A.F. acknowledges the support of the Internationalization Program of the Jerusalem College of Engineering (JCE) for conducting research activities in the laboratories of Profs. Haytam KASEM and Aiman ABU AMMAR.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Return